Jasper Therapeutics, Inc. (JSPRW) — DEF 14A Filings
All DEF 14A filings from Jasper Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Jasper Therapeutics Files Definitive Proxy Statement
— May 19, 2025 Risk: low
Jasper Therapeutics, Inc. filed a Definitive Proxy Statement (DEF 14A) on May 19, 2025, for its fiscal year ending December 31, 2025. The company, formerly know -
Jasper Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 22, 2024 Risk: low
Jasper Therapeutics, Inc. (JSPRW) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. Jasper Therapeutics, Inc. will hold its 2024 Annual Meeting
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX